About
Technology
Issues
FAQ
Links
Official Page
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.